Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s): QNTM

Healthcare

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.

CSE:QNTM - Post by User

Quantum BioPharma Ltd

Bullboard Posts

Comment by Fundy13on Dec 19, 2018 7:41am

126 Views

Post# 29133338

RE:RE:Zeeshan Continual Conversation with shareholders

NO, the little guys should not be hurt in that situation.
Bassically he is saying unless there is a large investor who is willing to invest at or obove the current SP when teh split occurs to support the price of the stock after the split then the split would not be done.
It may or may not be enough to stop the SP from falling after the split, but certainly would be better having the backing than not.

Bullboard Posts

Dollar Tree CEO Rick Dreiling steps down as discount retailer struggles